YHB Investment Advisors Inc. Sells 5,250 Shares of Align Technology, Inc. (NASDAQ:ALGN)

YHB Investment Advisors Inc. trimmed its holdings in Align Technology, Inc. (NASDAQ:ALGN) by 56.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 4,027 shares of the medical equipment provider’s stock after selling 5,250 shares during the quarter. YHB Investment Advisors Inc.’s holdings in Align Technology were worth $840,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Public Sector Pension Investment Board lifted its position in Align Technology by 84.7% in the second quarter. Public Sector Pension Investment Board now owns 2,539 shares of the medical equipment provider’s stock valued at $613,000 after purchasing an additional 1,164 shares during the last quarter. AXA S.A. raised its holdings in Align Technology by 955.9% during the 2nd quarter. AXA S.A. now owns 10,443 shares of the medical equipment provider’s stock valued at $2,521,000 after buying an additional 9,454 shares during the last quarter. MBB Public Markets I LLC purchased a new stake in Align Technology during the 2nd quarter valued at $1,289,000. Algert Global LLC bought a new stake in Align Technology in the 2nd quarter worth $333,000. Finally, Northwestern Mutual Wealth Management Co. increased its position in shares of Align Technology by 5.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 3,019 shares of the medical equipment provider’s stock valued at $729,000 after acquiring an additional 161 shares during the period. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on ALGN shares. Leerink Partners raised Align Technology from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $235.00 to $280.00 in a research note on Monday, January 6th. Evercore ISI reduced their target price on Align Technology from $270.00 to $250.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Leerink Partnrs raised Align Technology from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 6th. Bank of America boosted their price objective on shares of Align Technology from $200.00 to $206.00 and gave the company an “underperform” rating in a research report on Friday, December 13th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Align Technology in a research report on Monday, November 4th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $267.45.

Align Technology Price Performance

Shares of Align Technology stock opened at $226.17 on Wednesday. The firm’s 50-day moving average is $223.06 and its 200 day moving average is $227.33. Align Technology, Inc. has a 1 year low of $196.09 and a 1 year high of $335.40. The stock has a market cap of $16.88 billion, a price-to-earnings ratio of 38.60, a PEG ratio of 5.14 and a beta of 1.67.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.